New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 12, 2014
10:00 EDTANGO, SMLP, RAD, PMC, MCK, MRC, INFN, HTGC, GGP, EEFT, CALX, BDN, PAYOn The Fly: Analyst Upgrade Summary
AngioDynamics (ANGO) upgraded to Outperform from Market Perform at Raymond James... Brandywine Realty (BDN) upgraded to Equal Weight from Underweight at Barclays... Calix (CALX) upgraded to Neutral from Sell at Goldman... Euronet (EEFT) upgraded to Outperform from Market Perform at Avondale... General Growth (GGP) upgraded to Overweight from Equal Weight at Barclays... Hercules Technology (HTGC) upgraded to Outperform at Keefe Bruyette... Infinera (INFN) upgraded to Buy from Neutral at Goldman... MRC Global (MRC) upgraded to Buy from Neutral at Longbow... McKesson (MCK) upgraded to Conviction Buy from Buy at Goldman... PharMerica (PMC) upgraded to Outperform from Neutral at Credit Suisse... Rite Aid (RAD) upgraded to Buy from Neutral at Goldman... Summit Midstream (SMLP) upgraded to Outperform from Neutral at RW Baird... VeriFone (PAY) upgraded to Hold from Sell at Deutsche Bank.
Check below for free stories on ANGO;BDN;CALX;EEFT;GGP;HTGC;INFN;MRC;MCK;PMC;RAD;SMLP;PAY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 8, 2014
09:12 EDTINFNOn The Fly: Pre-market Movers
Subscribe for More Information
07:26 EDTMCKMorgan Stanley to hold a conference
Subscribe for More Information
05:33 EDTINFNInfinera upgraded to Buy from Hold at Jefferies
Jefferies upgraded Infinera to Buy on expectations the company's pending metro WDM product line will successful. The firm notes the product line will be at the company's September 18 analyst meeting. Jefferies raised its price target for shares to $14 from $10.50.
September 5, 2014
10:50 EDTPAYOptions with decreasing implied volatility
Subscribe for More Information
10:05 EDTPAYOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:30 EDTPAYApple iWallet would be positive for payment networks, says JPMorgan
Subscribe for More Information
06:00 EDTPAYVeriFone downgraded to Market Perform from Outperform at Raymond James
Raymond James downgraded VerFone to Market Perform due to valuation, ongoing reinvestments that limit upside profitability, and potentially peaking EMV demand at large customers.
September 4, 2014
10:59 EDTPAYOptions with decreasing implied volatility
Options with decreasing implied volatility: BIG GES CONN PAY ANF CIEN SPLK OVTI WDAY NAV
09:06 EDTPAYOn The Fly: Pre-market Movers
UP AFTER EARNINGS: PVH Corp. (PVH), up 9%... Verifone (PAY), up 3.8%... Methode Electronics (MEI), up 13%... Bazaarvoice (BV), up 9%. ALSO HIGHER: Bolt Technology (BOLT), up 35.7% after Teledyne (TDY) agrees to acquire the company for $22 per share in cash... Mitek Systems (MITK), up 58% after USAA lawsuit settlement... Tibco Software (TIBX), up 7% after announcing that it is reviewing strategic alternatives... Stereotaxis (STXS), up 22% after receiving FDA clearance for Vdrive with V-Loop system... NewLink (NLNK), up 3.4% after reporting FDA approval for Phase 1 clinical studies of Ebola vaccine. DOWN AFTER EARNINGS: Ciena (CIEN), down 3%... Joy Global (JOY), down 1%... Matrix Service (MTRX), down 11%... Mobileye (MBLY), down 1.3%. ALSO LOWER: Yum! Brands (YUM), down 2.8% after updating third quarter China division same-store sales guidance... 3D Systems (DDD), down 2.9% after downgraded at Pacific Crest... GoPro (GPRO), down 3.5% after downgraded at JPMorgan... Shanda Games (GAME), down 4% after announcing reconstitution of special committee.
08:31 EDTRADRite Aid reports August SSS up 3.9%
For the five weeks ended Aug. 30, 2014, same store sales increased 3.9% over the prior-year period. August front-end same store sales increased 1.1%. Pharmacy same store sales, which included an approximate 219 basis points negative impact from new generic introductions, increased 5.2%. Prescription count at comparable stores increased 3.7%over the prior-year period. Total drugstore sales for the five-week period increased 3.7% to $2.515B compared to $2.425B for the same period last year. Prescription sales accounted for 69.3% of drugstore sales, and third party prescription sales represented 97.5% of pharmacy sales. Same store sales for the 13-week period ended Aug. 30, 2014 increased 4.1% over the prior-year period. Front-end same store sales increased 1.1% while pharmacy same store sales increased 5.6 percent. Prescription count at comparable stores increased 3.7% over the prior-year period.
07:44 EDTSMLPSummit Midstream 4M share Spot Secondary priced at $53.88
Subscribe for More Information
07:36 EDTPAYVeriFone ups FY14 EPS view to $1.46-$1.47, consensus $1.45
Subscribe for More Information
07:35 EDTPAYVeriFone sees Q4 EPS 39c-40c, consensus 42c
Subscribe for More Information
07:34 EDTPAYVeriFone reports Q3 EPS 40c, consensus 35c
Subscribe for More Information
06:03 EDTRADStocks with implied volatility movement; WAG RAD
Subscribe for More Information
September 3, 2014
16:39 EDTSMLPSummit Midstream offers 4M common units owned by SMP Holdings
Subscribe for More Information
15:29 EDTPAYNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Joy Global (JOY), consensus 84c; VeriFone Systems (PAY), consensus 35c; Ciena (CIEN), consensus 29c; Mattress Firm (MFRM), consensus 60c; Methode Electronics (MEI), consensus 40c; UTi Worldwide (UTIW), consensus 1c.
10:00 EDTPMCOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:38 EDTPAYVeriFone Q3 results could bring another guidance raise, says Jefferies
Jefferies does not think expectations are too high into VeriFone's Q3 results tomorrow. The firm believes another FY14 guidance hike is possible, and that a beat and raise quarter would be positive for shares. Jefferies says the upside potential in Q3 is unlikely to be as big as Q2. It keeps a Buy rating on VeriFone with a $42 price target.
06:08 EDTPMCPharMerica upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use